Interferon gamma messenger RNA (IFNG mRNA) (IFNG mRNA)

Interferon gamma (IFN-γ) messenger RNA is the intermediate nucleic acid molecule that encodes the IFN-γ protein, a critical type II interferon involved in both innate and adaptive immunity (Source: NCBI Gene, ID: 3458). It is primarily synthesized by T helper 1 (Th1) cells, cytotoxic T cells, and natural killer (NK) cells in response to antigenic or inflammatory stimuli (Source: UniProt, P01579). The stability and translation of IFN-γ mRNA are tightly controlled by various RNA-binding proteins and microRNAs to prevent excessive inflammation (Source: PubMed, PMID: 28250445). In clinical contexts, this mRNA is a target for therapeutic modulation; for instance, RNA interference (RNAi) and antisense oligonucleotides are being researched to downregulate its expression in autoimmune diseases like rheumatoid arthritis or lupus (Source: PubMed, PMID: 31434126). Conversely, synthetic mRNA encoding IFN-γ is being investigated as a component of cancer vaccines to stimulate a robust anti-tumor immune response within the tumor microenvironment (Source: ClinicalTrials.gov). Monitoring IFN-γ mRNA levels serves as a vital biomarker for assessing immune activation and the efficacy of various immunotherapies (Source: PubMed, PMID: 25605875).

Other names

IFN-gamma mRNAImmune interferon mRNAType II interferon mRNAIFNG transcript

RNA interference (RNAi), antisense inhibition, or exogenous mRNA translation to modulate IFN-gamma protein levels.